Yale-Led Team Develops Nanosensors for Detecting Biomarkers in Whole Blood

According to its developers, their nanosensor can detect cancer protein biomarkers in whole blood for the first time, representing a "paradigm shift in label-free electronic sensing of biomolecules." They have launched a company to explore opportunities to commercialize the technology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.